ArticleActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2025
The Host-index in patients undergoing upfront surgery and free flap reconstruction for head and neck squamous cell carcinoma.
Article in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The Host-index (H-index) is a value obtained using blood laboratory parameters. Elevated H-index is a negative prognostic factor in patients with head and neck squamous cell carcinoma (HNSCC). The purpose of our study was to assess the prognostic impact of the H-Index in patients with locally advanced tumours who underwent reconstructive surgery with free flaps. Methods: We performed a retrospective study on a cohort of patients referred to our center from January 2013 to October 2018. We assessed the prognostic role of H-index in terms of disease-free (DFS) and overall survival (OS). Results: A total of 99 patients were studied, with a median age of 66 years. After a median follow-up of 46.5 months (range, 1.4-121.9), 5-year OS was 59.6% (CI 29.3-57.5) and 5-year DFS 47.5% (CI 16.7-49.2). The H-index showed a statistically significant correlation with a shorter DFS (HR 1.2, 95% CI 1.1-1.4, p = 0.006). No correlations were found between surgical complications and the H-index. Conclusions: This study confirmed that the H-index is an independent prognostic factor for DFS in patients with HNSCC undergoing microvascular reconstructive surgery and should be used to better stratify the risk of mortality and recurrence, with the aim of improving patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.